DM
Drugs Made In America Acquisition II Corp. Unit (DMIIU)
NASDAQ·Technology·General
$10.16
—
Mkt Cap $636.21M
Analyst Ratings
No recent rating data.
Price Target (28 analysts)
$233.45
Range $158.34 – $274.05
Implied Upside
+2197.7%
Consensus $233.45 vs current $10.16